Label: BHI MUCUS- antimony potassium tartrate,atropa belladonna,bryonia alba root,anemone americana,hyoscyamus niger,ipecac,lobelia inflata,human sputum, bordetella pertussis infected, and lobaria pulmonaria tablet
-
Contains inactivated NDC Code(s)
NDC Code(s): 50114-6922-2 - Packager: Heel Inc
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved homeopathic
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
Drug Label Information
Updated April 14, 2014
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- KEEP OUT OF REACH OF CHILREN
- INDICATIONS AND USAGE
-
WARNINGS
Warnings: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. Ask a doctor if you have a cough that occurs with too much phlegm (mucus) or a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema. Stop and ask a doctor if cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition. Do not use if known sensitivity to Mucus Relief or any of its ingredients exists.
-
DOSAGE
Directions: At first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.
Standard dosage: Adults and children 4 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours.
For children under 4, consult your healthcare provider.
Allow tablets to dissolve completely in the mouth, do not swallow.
- ACTIVE INGREDIENTS
- INACTIVE INGREDIENTS
- PURPOSE
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BHI MUCUS
antimony potassium tartrate,atropa belladonna,bryonia alba root,anemone americana,hyoscyamus niger,ipecac,lobelia inflata,human sputum, bordetella pertussis infected, and lobaria pulmonaria tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50114-6922 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ANTIMONY POTASSIUM TARTRATE (UNII: DL6OZ476V3) (ANTIMONY CATION (3+) - UNII:069647RPT5) ANTIMONY POTASSIUM TARTRATE 5 [hp_X] ATROPA BELLADONNA (UNII: WQZ3G9PF0H) (ATROPA BELLADONNA - UNII:WQZ3G9PF0H) ATROPA BELLADONNA 6 [hp_X] BRYONIA ALBA ROOT (UNII: T7J046YI2B) (BRYONIA ALBA ROOT - UNII:T7J046YI2B) BRYONIA ALBA ROOT 6 [hp_X] ANEMONE AMERICANA (UNII: 6ICN6T7FEM) (ANEMONE AMERICANA - UNII:6ICN6T7FEM) ANEMONE AMERICANA 6 [hp_X] HYOSCYAMUS NIGER (UNII: 4WRK2153H3) (HYOSCYAMUS NIGER - UNII:4WRK2153H3) HYOSCYAMUS NIGER 5 [hp_X] IPECAC (UNII: 62I3C8233L) (IPECAC - UNII:62I3C8233L) IPECAC 6 [hp_X] LOBELIA INFLATA (UNII: 9PP1T3TC5U) (LOBELIA INFLATA - UNII:9PP1T3TC5U) LOBELIA INFLATA 4 [hp_X] HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED (UNII: U364V64HUN) (HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED - UNII:U364V64HUN) HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED 30 [hp_X] LOBARIA PULMONARIA (UNII: D1YM0P5Z2T) (LOBARIA PULMONARIA - UNII:D1YM0P5Z2T) LOBARIA PULMONARIA 5 [hp_X] Inactive Ingredients Ingredient Name Strength LACTOSE (UNII: J2B2A4N98G) MAGNESIUM STEARATE (UNII: 70097M6I30) Product Characteristics Color white Score no score Shape ROUND Size 9mm Flavor Imprint Code BHI;O;M Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50114-6922-2 100 in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 01/31/1993 Labeler - Heel Inc (102783016) Establishment Name Address ID/FEI Business Operations Heel Inc 102783016 manufacture(50114-6922)
